Is Athira Pharma Inc (ATHA) overvalued? · $26.6M cap
Athira Pharma Inc (ATHA) is a biotechnology company listed on US.
This page asks whether Athira Pharma Inc (ATHA) looks expensive on cached numbers — not a short thesis.
No cached income statement for ATHA, so there is no earnings base to call rich or cheap.
ATHA currently screens at market cap $26.6M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ATHA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ATHA stock page for the full model, not this heading.
Not investment advice.